There is a need for proteomic analysis of subcellular cytoskeleton compartments in immune cells, especially the thus far entirely overlooked nuclear skeleton proteome. Available methodological ...
proteomic and transcriptomic characteristics that more precisely describe cancer subtypes. Andrew D. Cherniack, Ph.D., of the Broad Institute of MIT and Harvard and Kyle Ellrott, Ph.D., of the ...
proteomic and transcriptomic characteristics that more precisely describe cancer subtypes. Andrew D. Cherniack, Ph.D., of the Broad Institute of MIT and Harvard and Kyle Ellrott, Ph.D., of the ...
Hosted on MSN16d
Protein CD74 can predict immunotherapy response in bowel cancer, independent of subtypeCancer immunotherapy drugs, which boost the immune system to fight the tumor, have revolutionized the treatment of the deficient subtype of colorectal cancer. However, these drugs only work in ...
Yet little is known about the immune cell subtypes most responsive to IL-1β induced inflammatory signals in humans. We have developed a custom CyTOF panel and have identified the immune cell targets ...
By identifying novel CBPs, proteomic approaches can lead to the generation of hypotheses to direct further investigations aimed at improving our understanding of cytoskeleton-dependent immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback